Aurobindo Pharma Q1 PAT seen up 1.3% YoY to Rs 791.1 cr: KRChoksey

Trade

• Watchlist
• Portfolio
• Message
• Set Alert

 

 

live

• bselive
• nselive

Volume

Todays L/H

More

×

KRChoksey has come out with its first quarter (April-June’ 21) earnings estimates for the Pharma sector. The brokerage house expects Aurobindo Pharma to report net profit at Rs 791.1 crore up 1.3% year-on-year (down 1.3% quarter-on-quarter).

Net Sales are expected to increase by 3.8 percent Y-o-Y (up 2.4 percent Q-o-Q) to Rs 6,148 crore, according to KRChoksey.

Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 2.3 percent Y-o-Y (up 1 percent Q-o-Q) to Rs 1,286.2 crore.

Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

Read More